Radiation boost may extend life in early-spread lung cancer

NCT ID NCT06141070

Recruiting now Disease control Sponsor: Vastra Gotaland Region Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding targeted, high-dose radiation to standard drug therapy (chemotherapy or immunotherapy) helps people with non-small cell lung cancer that has spread to up to 5 spots live longer. About 240 participants will be randomly assigned to receive either standard treatment alone or standard treatment plus radiation to all known cancer spots. The main goal is to see if the combination improves overall survival.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SMALL CELL LUNG CANCER

Contacts and locations

Locations

Dept of Oncology
RECRUITING

Gothenburg, 41345, Sweden
Dept of Oncology
RECRUITING

Stockholm, Sweden
Dept of pulmonary medicine
NOT_YET_RECRUITING

Linköping, Sweden
Dept of pulmonary medicine
NOT_YET_RECRUITING

Lund, Sweden
Dept. of Oncology
RECRUITING

Umeå, Sweden
Dept. of Oncology
RECRUITING

Uppsala, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.